EXECUTIVE CHANGE IN CONTROL & GENERAL SEVERANCE AGREEMENTGeneral Severance Agreement • August 6th, 2018 • Advanced Energy Industries Inc • Electronic components, nec • Colorado
This Executive Change in Control & General Severance Agreement (this “Agreement”), is made as of the ___ day of ________, 20__ (the “Effective Date”), by and between Advanced Energy Industries, Inc., a Delaware corporation (the “Company”), and [NAME] (the “Executive”).
GENERAL SEVERANCE AGREEMENTGeneral Severance Agreement • February 12th, 2013 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New Jersey
This General Severance Agreement (the “Agreement”) is made as of the 12 day of February, 2013, between Enzon Pharmaceuticals, Inc., a Delaware corporation, with offices in Piscataway, New Jersey (the “Company”), and Timothy G. Daly (“Executive”), a resident of [REDACTED].
FORM OF EXECUTIVE CHANGE IN CONTROL & GENERAL SEVERANCE AGREEMENTGeneral Severance Agreement • November 8th, 2023 • Advanced Energy Industries Inc • Electronic components, nec
This Executive Change in Control & General Severance Agreement (this “Agreement”), is made as of the [ ] day of [month] [year] (the “Effective Date”), by and between Advanced Energy Industries, Inc., a Delaware corporation (the “Company”), and [ name ] (the “Executive”).
AMENDED AND RESTATED GENERAL SEVERANCE AGREEMENTGeneral Severance Agreement • November 23rd, 2011 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New Jersey
This Amended and Restated General Severance Agreement (the “Agreement”) is made as of the 22 day of November, 2011, between Enzon Pharmaceuticals, Inc., a Delaware corporation, with offices in Bridgewater, New Jersey (the “Company”), and Ana I. Stancic (“Executive”), a resident of New Jersey, and supersedes and replaces that Severance Agreement, dated as of June 8, 2011, by and between the Company and Executive (the “Previous Agreement”).
GENERAL SEVERANCE AGREEMENTGeneral Severance Agreement • May 31st, 2011 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New Jersey
This General Severance Agreement (the “Agreement”) is made as of the 8th day of June, 2011, between Enzon Pharmaceuticals, Inc., a Delaware corporation, with offices in Bridgewater, New Jersey (the “Company”), and Ana I. Stancic (“Executive”), a resident of New Jersey.
